Review
Evaluation
Target price
Dynamics
Performance
Growth
Dividends
Risks
$ 0.33
Key Takeaways
Risk factor
Very high price volatility
Data is available to registered users only
Data is available to registered users only
Profitability factor
Very low or no dividends
Data is available to registered users only
Data is available to registered users only
About
Medicus Pharma Ltd. is a biotech/life sciences company focused on accelerating the clinical development programs of novel and disruptive therapeutic assets, with an emphasis on non-invasive treatments for skin cancer.
Company Valuation
From both historical and forecast perspectives, the stock is fairly priced compared to similar stocks.
Data is available to registered users only
